Crowdonomics
WatchlistPortfolio
Isosceles Pharmaceuticals, Inc.

Reg CF · Common Stock · Oct 2022

ClosedReg CFCommon Equity
via Private · last checked Sep 23, 2026
Raised
$0 / $5M max
0% of ceiling
Investors
—
—
Estimated pre-money
$23.9M
—

Financials disclosed in this offering

FY2020–FY2021 · hover for source
$0
$892K
FY2020
$0
$880K
FY2021
RevenueNet income
Metric
FY2020 audited
FY2021 audited
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
$891,911
$879,786
Taxes paid
$0
$0
Balance sheet
Cash
$198,240
$212,834
Accounts receivable
$0
$0
Total assets
$198,240
$212,834
Short-term debt
$0
$0
Long-term debt
$0
$120,000
Total liabilities
$0
$120,000
Other
Headcount
—
10

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Deal terms

Est. pre-money$23.9M
Price / share$2.05
Shares offered9,756

Estimated, not stated: $2.05 × 11,641,109 securities outstanding as of Dec 31, 2021 (Form C filed Oct 3, 2022, p. 50).

Offering details

Target$20,000
Max$5,000,000
Min investment—
OpenedOct 3, 2022
DeadlineOct 2, 2023
ClosedOct 2, 2023
Days active364

Links & provenance

SEC filing
Source: SEC EDGAR
0001213900-22-061146
Last synced Sep 23, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.